Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Combination With Atezo vs. Regorafenib in Previously Treated mCRC"

47 views
July 2, 2023
Comments 0
Login to view comments. Click here to Login